Healthcare: Counting the cost of cancer - Financial Times | Immunology and Biotherapies | Scoop.it

The cancer drug market in 2013 was over $90 billion and increasing as the number of elderly and cancer patients increases all over the world. 

 

 

 


Via Krishan Maggon